StockNews.com Initiates Coverage on Ligand Pharmaceuticals (

Stock analysts at StockNews.com started coverage on shares of Ligand Pharmaceuticals (NASDAQ:LGND – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the biotechnology company’s stock. A number of other research analysts also recently commented on the company. TheStreet downgraded Ligand Pharmaceuticals from a “b-” rating to a […]

Related Keywords

Arizona , United States , Toddc Davis , , Advisor Group Holdings Inc , Ligand Pharmaceuticals Trading , Barclays , Ligand Pharmaceuticals , Institutional Trading Of Ligand Pharmaceuticals , Ligand Pharmaceuticals Incorporated , News Ratings For Ligand Pharmaceuticals Daily , Campbell Co Investment Adviser , Ameritas Investment Partners Inc , Get Free Report , Group Holdings , State Retirement System , Ameritas Investment Partners , Investment Partners , Pharmaceuticals Incorporated , Ligand Pharmaceuticals Daily , Nasdaq Lgnd , Lgnd , Medical , 53220k50 , Initiated Coverage , Stocknews Com ,